Cytodyn Inc (CYDY)

[The Lawman]

Some have suggested that Pourhassan should be retained as CEO, and deserves a rich compensation package, because he salvaged leronlimab (then known as PRO 140) from Progenics, with his own funds and hard work.

However, what Pourhassan may or may not have done many years ago is of no moment now.

In the 4+ years I have invested in Cytodyn, the SP has declined dramatically, and many promises made by Pourhassan have gone unfulfilled.

I invested, in large part, based upon these unfulfilled promises, as I am sure many others did as well.

I have come to believe in the past 4+ years, that Pourhassan lacks the knowledge, background, experience, and disposition needed to lead Cytodyn forward at this point in its existence.

Notwithstanding what I perceive to be Pourhassan's lack of competence and credibility, he has been taking what I consider to be a grossly excessive compensation package, that to my astonishment and chagrin, was increased this past year by 50%, while the SP plummeted.

To add insult to injury, Pourhassan has not purchased one share of stock on the open market, to my knowledge, while continually telling shareholders the SP is greatly undervalued, and will shortly reach an inflection point.

If Pourhassan truly believed this, one would think he would be purchasing stock hand over fist.

To put it bluntly, I no longer believe anything Pourhassan says.

Regardless of what Pourhassan may have done for the company many years ago, he has been repaid many times over, and is owed nothing for his past efforts.

Given my belief that Pourhassan is not the right person to lead this company forward, at this stage of its existence, he should, in my opinion, be replaced with someone who has the knowledge, background, and experience in successfully leading a clinical stage biopharma.

While others may disagree, which is their right, for my money--and I have a lot of that on the line with this company--I strongly recommend that Pourhassan to be replaced, and replaced asap.

LM